Ayala is an Arc Ventures portfolio company since 2018 . The official press release can be found on the company's website. REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and…
Orgenesis, a pioneering, global biotech company committed to lowering costs, accelerating commercialization, and transforming the delivery of cell and gene therapies (CGTs), announces it has entered into an agreement to acquire the assets of Tamir Bio, including ranpirnase, TamirBio’s broad spectrum anti-viral platform.
Good old fashioned ideas like 'cost-saving', 'governance' and 'social responsibility' and even, dare I say it, 'profits' are back en vogue. What happened?
Intuitive acquires Orpheus Medical to expand informatics platform for hospitals. “Combining both companies’ innovative technologies with Intuitive’s global reach and resources will enable current and future customers easier and faster access to their data,” said Gaddi Menahem, CEO of Orpheus Medical.
Vayyar Imaging today announced it closed a $109 million Series D financing round led by Koch Disruptive Technologies (Koch), with Regal Four and all existing investors including Battery Ventures, Bessemer Ventures, ICV, ITI, WRVI Capital, Claltech, bringing the total capital raised to-date to $188 million USD.